MIKHAIL BLAGOSKLONNY’S DEDICATION TO CANCER TREATMENT

Mikhail Blagosklonny is an oncologist who works at Roswell Park Cancer center where he has worked as a professor of oncology since 2009. Before this, Blagosklonny worked at Ordway Research Institute as a senior scientist; a job he started in 2002 when he stopped his teaching job at New York Medical College. He studied at First Pavlov State Medical University, St. Peterburg for his masters and Ph.D. in internal medicine and cardiology & experiment medicine respectively. His experience in oncology has led him to sit on the boards of various cancer institutes. Check Mikhail’s profile on Loop

He specializes in the treatment therapy for aging and cancer. His research has led to his hypothesis that argues that TOR (Target Of Rapamycin) has impact in the body’s aging and cell growth process. TOR determines how the body cells respond to the various environmental factors such as stress, energy and food availability that trigger aging and cell development. In his research on the various methods of treating cancer and aging, he discovered that rapamycin, a component found in most of the cancer drugs can be used to delay the aging process in most of the organisms. His research focuses on substances that could be useful in the treatment of cancer.

Mikhail Blagosklonny is a committed oncologist who seeks to make the world a better place through his contribution to the field of oncology. His passion for cancer treatment has led to his editorial jobs. Blagosklonny edits some of the famous medical journals especially those that write about oncology and cancer treatment. He is the editor in chief of Aging, a medical journal the covers topics such as gerontology and the molecular mechanisms involved in the process of aging. He is a part of the editorial board of Cell Death & Differentiation and the associate editor to Cancer Biology &Therapy. Blagosklonny is also the chief editor of Oncotarget. Oncotarget is a freely accessible medical journal that focuses on the articles addressing issues in the field of oncology. Mikhail Blagosklonny’s experience and commitment to curing aging and cancer has made him a person fit to give lectures in cancer institutions as well as head many health science organizations. View Mikhail’s profile on Google Scholar

Leave a Reply

Your email address will not be published. Required fields are marked *